Trial finds 3 days of lower dose noninferior to higher-dose, 7 day regimen Although amoxicillin is widely recognized for treatment of community acquired pneumonia (CAP) in young children, the optimal dose and optimal duration of therapy remain unclear, as neither have been widely studied. For example, in 2011 the Infectious Diseases Society of America recommended